Australian biotech says it can regrow parts of heart

10/17/2005 | Sydney Morning Herald (Australia), The

Researchers at Melbourne's biotech company Mesoblast say they found a rare cell in bone marrow that can begin the regrowth process for heart muscles and arteries when it is injected into a patient and a way to grow the cell outside the body. Researchers say they will plan clinical trials in the next two months with expectations of an anti-heart disease drug being available for sale within three years.

View Full Article in:

Sydney Morning Herald (Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY